{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:45:14Z","timestamp":1794357914715,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100705"],"award-info":[{"award-number":["82100705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070713"],"award-info":[{"award-number":["82070713"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiolipin (CL) plays a critical role in maintaining mitochondrial membrane integrity and overall mitochondrial homeostasis. Recent studies have suggested that mitochondrial damage resulting from abnormal cardiolipin remodelling is associated with the pathogenesis of diabetic kidney disease (DKD). Acyl-coenzyme A:lyso-cardiolipin acyltransferase-1 (ALCAT1) was confirmed to be involved in the progression of Parkinson\u2019s disease, diet-induced obesity and other ageing-related diseases by regulating pathological cardiolipin remodelling. Thus, the purpose of this investigation was to determine the role of ALCAT1-mediated CL remodelling in DKD and to explore the potential underlying mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In vivo study, the mitochondrial structure was examined by transmission electron microscopy (TEM). The colocalization of ALCAT1 and synaptopodin was evaluated by double immunolabelling. Western blotting (WB) was performed to assess ALCAT1 expression in glomeruli. Lipidomics analysis was conducted to evaluate the composition of reconstructed cardiolipins. In vitro study, the lipidomics, TEM and WB analyses were similar to those in vivo. Mitochondrial function was evaluated by measuring the mitochondrial membrane potential (MMP) and the production of ATP and ROS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we showed that increased oxidized cardiolipin (ox-CL) and significant mitochondrial damage were accompanied by increased ALCAT1 expression in the glomeruli of patients with DKD. Similar results were found in db\/db mouse kidneys and in cultured podocytes stimulated with high glucose (HG). ALCAT1 deficiency effectively prevented HG-induced ox-CL production and mitochondrial damage in podocytes. In contrast, ALCAT1 upregulation enhanced ox-CL levels and podocyte mitochondrial dysfunction. Moreover, treatment with the cardiolipin antioxidant SS-31 markedly inhibited mitochondrial dysfunction and cell injury, and SS-31 treatment partly reversed the damage mediated by ALCAT1 overexpression. We further found that ALCAT1 could mediate the key regulators of mitochondrial dynamics and mitophagy through the AMPK pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, our studies demonstrated that ALCAT1-mediated cardiolipin remodelling played a crucial role in DKD, which might provide new insights for DKD treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-023-01399-4","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T07:02:41Z","timestamp":1704870161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["ALCAT1-mediated abnormal cardiolipin remodelling promotes mitochondrial injury in podocytes in diabetic kidney disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Yiqun","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilv","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"1399_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMc1602469","volume":"375","author":"L Zhang","year":"2016","unstructured":"Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, et al. Trends in chronic Kidney Disease in China. N Engl J Med. 2016;375:905\u20136.","journal-title":"N Engl J Med"},{"key":"1399_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00125-018-4557-7","volume":"61","author":"RCW Ma","year":"2018","unstructured":"Ma RCW. Epidemiology of Diabetes and diabetic Complications in China. Diabetologia. 2018;61:1249\u201360.","journal-title":"Diabetologia"},{"key":"1399_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic Kidney Disease: impact of SGLT2 inhibitors. Nat Rev Nephrol. 2021;17:319\u201334.","journal-title":"Nat Rev Nephrol"},{"key":"1399_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/joim.13424","volume":"291","author":"M Guedes","year":"2022","unstructured":"Guedes M, Pecoits-Filho R. Can we cure diabetic Kidney Disease? Present and future perspectives from a nephrologist\u2019s point of view. J Intern Med. 2022;291:165\u201380.","journal-title":"J Intern Med"},{"key":"1399_CR5","doi-asserted-by":"publisher","first-page":"e15644","DOI":"10.14814\/phy2.15644","volume":"11","author":"Y Tao","year":"2023","unstructured":"Tao Y, Young-Stubbs C, Yazdizadeh Shotorbani P, Su DM, Mathis KW, Ma R. Sex and strain differences in renal hemodynamics in mice. Physiol Rep. 2023;11:e15644.","journal-title":"Physiol Rep"},{"key":"1399_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/15353702221139187","volume":"248","author":"Y Tao","year":"2023","unstructured":"Tao Y, Mallet RT, Mathis KW, Ma R. Store-operated ca(2+) channel signaling: novel mechanism for podocyte injury in Kidney Disease. Exp Biol Med (Maywood). 2023;248:425\u201333.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1399_CR7","doi-asserted-by":"publisher","first-page":"101990","DOI":"10.1016\/j.jbc.2022.101990","volume":"298","author":"Y Tao","year":"2022","unstructured":"Tao Y, Chaudhari S, Shotorbani PY, Ding Y, Chen Z, Kasetti R, Zode G, Ma R. Enhanced Orai1-mediated store-operated ca(2+) channel\/calpain signaling contributes to high glucose-induced podocyte injury. J Biol Chem. 2022;298:101990.","journal-title":"J Biol Chem"},{"key":"1399_CR8","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1002\/jcp.29646","volume":"235","author":"Z Chen","year":"2020","unstructured":"Chen Z, Ma Y, Yang Q, Hu J, Feng J, Liang W, Ding G. AKAP1 mediates high glucose-induced mitochondrial fission through the phosphorylation of Drp1 in podocytes. J Cell Physiol. 2020;235:7433\u201348.","journal-title":"J Cell Physiol"},{"key":"1399_CR9","doi-asserted-by":"publisher","first-page":"155194","DOI":"10.1016\/j.metabol.2022.155194","volume":"131","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Hu J, Chen Z, Feng J, Yang X, Liang W, Ding G. Transition of acute kidney injury to chronic Kidney Disease: role of metabolic reprogramming. Metabolism. 2022;131:155194.","journal-title":"Metabolism"},{"key":"1399_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41401-021-00788-0","volume":"43","author":"JY He","year":"2022","unstructured":"He JY, Hong Q, Chen BX, Cui SY, Liu R, Cai GY, Guo J, Chen XM. Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity. Acta Pharmacol Sin. 2022;43:342\u201353.","journal-title":"Acta Pharmacol Sin"},{"key":"1399_CR11","doi-asserted-by":"publisher","first-page":"F494","DOI":"10.1152\/ajprenal.00297.2022","volume":"324","author":"Y Tao","year":"2023","unstructured":"Tao Y, Yazdizadeh Shotorbani P, Inman D, Das-Earl P, Ma R. Store-operated ca(2+) entry inhibition ameliorates high glucose and ANG II-induced podocyte apoptosis and mitochondrial damage. Am J Physiol Renal Physiol. 2023;324:F494\u2013f504.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1399_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1530\/EC-19-0234","volume":"8","author":"Y Ma","year":"2019","unstructured":"Ma Y, Chen Z, Tao Y, Zhu J, Yang H, Liang W, Ding G. Increased mitochondrial fission of glomerular podocytes in diabetic Nephropathy. Endocr Connect. 2019;8:1206\u201312.","journal-title":"Endocr Connect"},{"key":"1399_CR13","doi-asserted-by":"publisher","first-page":"C33","DOI":"10.1152\/ajpcell.00243.2006","volume":"292","author":"AJ Chicco","year":"2007","unstructured":"Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and Disease. Am J Physiol Cell Physiol. 2007;292:C33\u201344.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1399_CR14","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1007\/s00018-014-1648-6","volume":"71","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Tamura Y, Roy M, Adachi Y, Iijima M, Sesaki H. Biosynthesis and roles of phospholipids in mitochondrial fusion, division and mitophagy. Cell Mol Life Sci. 2014;71:3767\u201378.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"1399_CR15","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/cells11121906","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang J, Shi Y. In Search of the Holy Grail: Toward a Unified Hypothesis on Mitochondrial Dysfunction in Age-Related Diseases. Cells. 2022;11(12):1906.","journal-title":"Cells."},{"key":"1399_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2010.07.003","volume":"12","author":"J Li","year":"2010","unstructured":"Li J, Romestaing C, Han X, Li Y, Hao X, Wu Y, Sun C, Liu X, Jefferson LS, Xiong J, et al. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab. 2010;12:154\u201365.","journal-title":"Cell Metab"},{"key":"1399_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.jbchem.a021715","volume":"122","author":"A Yamashita","year":"1997","unstructured":"Yamashita A, Sugiura T, Waku K. Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J Biochem. 1997;122:1\u201316.","journal-title":"J Biochem"},{"key":"1399_CR18","doi-asserted-by":"publisher","first-page":"31727","DOI":"10.1074\/jbc.M402930200","volume":"279","author":"J Cao","year":"2004","unstructured":"Cao J, Liu Y, Lockwood J, Burn P, Shi Y. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J Biol Chem. 2004;279:31727\u201334.","journal-title":"J Biol Chem"},{"key":"1399_CR19","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1016\/j.ymthe.2021.06.007","volume":"29","author":"D Jia","year":"2021","unstructured":"Jia D, Zhang J, Nie J, Andersen JP, Rendon S, Zheng Y, Liu X, Tian Z, Shi Y. Cardiolipin remodeling by ALCAT1 links hypoxia to coronary artery Disease by promoting mitochondrial dysfunction. Mol Ther. 2021;29:3498\u2013511.","journal-title":"Mol Ther"},{"key":"1399_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/35036395","volume":"2","author":"M Lutter","year":"2000","unstructured":"Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol. 2000;2:754\u201361.","journal-title":"Nat Cell Biol"},{"key":"1399_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nchembio727","volume":"1","author":"VE Kagan","year":"2005","unstructured":"Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol. 2005;1:223\u201332.","journal-title":"Nat Chem Biol"},{"key":"1399_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1161\/01.RES.0000109416.56608.64","volume":"94","author":"G Paradies","year":"2004","unstructured":"Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, Ruggiero FM. Decrease in mitochondrial complex I activity in ischemic\/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res. 2004;94:53\u20139.","journal-title":"Circ Res"},{"key":"1399_CR23","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1172\/JCI125316","volume":"129","author":"GM Ducasa","year":"2019","unstructured":"Ducasa GM, Mitrofanova A, Mallela SK, Liu X, Molina J, Sloan A, Pedigo CE, Ge M, Santos JV, Hernandez Y, et al. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. J Clin Invest. 2019;129:3387\u2013400.","journal-title":"J Clin Invest"},{"key":"1399_CR24","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1073\/pnas.1120043109","volume":"109","author":"J Li","year":"2012","unstructured":"Li J, Liu X, Wang H, Zhang W, Chan DC, Shi Y. Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression. Proc Natl Acad Sci U S A. 2012;109:6975\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1399_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.27420","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang L, Liu X, Nie J, Zhang J, Kimball SR, Zhang H, Zhang WJ, Jefferson LS, Cheng Z, Ji Q, Shi Y. ALCAT1 controls mitochondrial etiology of fatty Liver Diseases, linking defective mitophagy to steatosis. Hepatology. 2015;61:486\u201396.","journal-title":"Hepatology"},{"key":"1399_CR26","doi-asserted-by":"publisher","first-page":"e12941","DOI":"10.1111\/acel.12941","volume":"18","author":"C Song","year":"2019","unstructured":"Song C, Zhang J, Qi S, Liu Z, Zhang X, Zheng Y, Andersen JP, Zhang W, Strong R, Martinez PA, et al. Cardiolipin remodeling by ALCAT1 links mitochondrial dysfunction to Parkinson\u2019s Diseases. Aging Cell. 2019;18:e12941.","journal-title":"Aging Cell"},{"key":"1399_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.apsb.2020.10.024","volume":"11","author":"X Jing","year":"2021","unstructured":"Jing X, Ren D, Gao F, Chen Y, Wu X, Han Y, Han Q, Li L, Wang X, Tang W, Zhang Y. Gene deficiency or pharmacological inhibition of PDCD4-mediated FGR signaling protects against acute kidney injury. Acta Pharm Sin B. 2021;11:394\u2013405.","journal-title":"Acta Pharm Sin B"},{"key":"1399_CR28","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1089\/hum.2019.127","volume":"30","author":"JD Rubin","year":"2019","unstructured":"Rubin JD, Nguyen TV, Allen KL, Ayasoufi K, Barry MA. Comparison of Gene Delivery to the kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral vectors after intravenous and direct kidney injections. Hum Gene Ther. 2019;30:1559\u201371.","journal-title":"Hum Gene Ther"},{"key":"1399_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.kint.2016.06.013","volume":"90","author":"HH Szeto","year":"2016","unstructured":"Szeto HH, Liu S, Soong Y, Alam N, Prusky GT, Seshan SV. Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney Int. 2016;90:997\u20131011.","journal-title":"Kidney Int"},{"key":"1399_CR30","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/ndt\/gfy021","volume":"33","author":"Y Hou","year":"2018","unstructured":"Hou Y, Shi Y, Han B, Liu X, Qiao X, Qi Y, Wang L. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic Nephropathy. Nephrol Dial Transplant. 2018;33:1908\u201318.","journal-title":"Nephrol Dial Transplant"},{"key":"1399_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.7150\/ijbs.39936","volume":"16","author":"Y Wu","year":"2020","unstructured":"Wu Y, Yan B, Xu W, Guo L, Wang Z, Li G, Hou N, Zhang J, Ling R. Compound C enhances the anticancer effect of aspirin in HER-2-positive Breast cancer by regulating lipid metabolism in an AMPK-independent pathway. Int J Biol Sci. 2020;16:583\u201397.","journal-title":"Int J Biol Sci"},{"key":"1399_CR32","doi-asserted-by":"publisher","first-page":"105783","DOI":"10.1016\/j.phrs.2021.105783","volume":"171","author":"XW Ding","year":"2021","unstructured":"Ding XW, Robinson M, Li R, Aldhowayan H, Geetha T, Babu JR. Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer\u2019s Disease. Pharmacol Res. 2021;171:105783.","journal-title":"Pharmacol Res"},{"issue":"17","key":"1399_CR33","doi-asserted-by":"publisher","first-page":"9675","DOI":"10.3390\/ijms23179675","volume":"23","author":"M Lee","year":"2022","unstructured":"Lee M, Ham NY, Hwang CY, Jang J, Lee B, Jeong JW, Kang I, Yeo EJ. Compound C inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse models by blocking cell cycle progression, Adhesion and Invasion. Int J Mol Sci. 2022;23(17):9675.","journal-title":"Int J Mol Sci."},{"key":"1399_CR34","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1039\/D0FO03467C","volume":"12","author":"Y Fan","year":"2021","unstructured":"Fan Y, Cheng J, Yang Q, Feng J, Hu J, Ren Z, Yang H, Yang D, Ding G. Sirt6-mediated Nrf2\/HO-1 activation alleviates angiotensin II-induced DNA DSBs and apoptosis in podocytes. Food Funct. 2021;12:7867\u201382.","journal-title":"Food Funct"},{"key":"1399_CR35","doi-asserted-by":"publisher","first-page":"116941","DOI":"10.1016\/j.lfs.2019.116941","volume":"237","author":"J Feng","year":"2019","unstructured":"Feng J, Ma Y, Chen Z, Hu J, Yang Q, Ding G. Mitochondrial pyruvate carrier 2 mediates mitochondrial dysfunction and apoptosis in high glucose-treated podocytes. Life Sci. 2019;237:116941.","journal-title":"Life Sci"},{"key":"1399_CR36","doi-asserted-by":"publisher","first-page":"110443","DOI":"10.1016\/j.cellsig.2022.110443","volume":"99","author":"Z Luo","year":"2022","unstructured":"Luo Z, Chen Z, Zhu Z, Hao Y, Feng J, Luo Q, Zhang Z, Yang X, Hu J, Liang W, Ding G. Angiotensin II induces podocyte metabolic reprogramming from glycolysis to glycerol-3-phosphate biosynthesis. Cell Signal. 2022;99:110443.","journal-title":"Cell Signal"},{"key":"1399_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/15548627.2015.1023984","volume":"11","author":"P Hsu","year":"2015","unstructured":"Hsu P, Liu X, Zhang J, Wang HG, Ye JM, Shi Y. Cardiolipin remodeling by TAZ\/tafazzin is selectively required for the initiation of mitophagy. Autophagy. 2015;11:643\u201352.","journal-title":"Autophagy"},{"key":"1399_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.7150\/ijbs.29323","volume":"15","author":"Y Fan","year":"2019","unstructured":"Fan Y, Yang Q, Yang Y, Gao Z, Ma Y, Zhang L, Liang W, Ding G. Sirt6 suppresses high glucose-Induced mitochondrial dysfunction and apoptosis in Podocytes through AMPK activation. Int J Biol Sci. 2019;15:701\u201313.","journal-title":"Int J Biol Sci"},{"key":"1399_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41419-019-1754-3","volume":"10","author":"D Zhou","year":"2019","unstructured":"Zhou D, Zhou M, Wang Z, Fu Y, Jia M, Wang X, Liu M, Zhang Y, Sun Y, Lu Y, et al. PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic Nephropathy. Cell Death Dis. 2019;10:524.","journal-title":"Cell Death Dis"},{"key":"1399_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tibs.2011.09.003","volume":"37","author":"SM Claypool","year":"2012","unstructured":"Claypool SM, Koehler CM. The complexity of cardiolipin in health and Disease. Trends Biochem Sci. 2012;37:32\u201341.","journal-title":"Trends Biochem Sci"},{"key":"1399_CR41","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1074\/jbc.RA119.011110","volume":"295","author":"S Miyamoto","year":"2020","unstructured":"Miyamoto S, Zhang G, Hall D, Oates PJ, Maity S, Madesh M, Han X, Sharma K. Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db\/db mice against progression of diabetic Kidney Disease. J Biol Chem. 2020;295:7249\u201360.","journal-title":"J Biol Chem"},{"key":"1399_CR42","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/bph.12468","volume":"171","author":"AV Birk","year":"2014","unstructured":"Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH. Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol. 2014;171:2017\u201328.","journal-title":"Br J Pharmacol"},{"key":"1399_CR43","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.kint.2016.10.036","volume":"91","author":"MT Sweetwyne","year":"2017","unstructured":"Sweetwyne MT, Pippin JW, Eng DG, Hudkins KL, Chiao YA, Campbell MD, Marcinek DJ, Alpers CE, Szeto HH, Rabinovitch PS, Shankland SJ. The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age. Kidney Int. 2017;91:1126\u201345.","journal-title":"Kidney Int"},{"key":"1399_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41436-020-01006-8","volume":"23","author":"W Reid Thompson","year":"2021","unstructured":"Reid Thompson W, Hornby B, Manuel R, Bradley E, Laux J, Carr J, Vernon HJ. A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism. Genet Med. 2021;23:471\u20138.","journal-title":"Genet Med"},{"key":"1399_CR45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/jcsm.12559","volume":"11","author":"A Karaa","year":"2020","unstructured":"Karaa A, Haas R, Goldstein A, Vockley J, Cohen BH. A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. J Cachexia Sarcopenia Muscle. 2020;11:909\u201318.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1399_CR46","doi-asserted-by":"crossref","unstructured":"Audzeyenka I, Bier\u017cy\u0144ska A, Lay AC. Podocyte Bioenergetics in the Development of Diabetic Nephropathy: the role of Mitochondria. Endocrinol. 2022;163(1):bqab234.","DOI":"10.1210\/endocr\/bqab234"},{"key":"1399_CR47","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1080\/15548627.2022.2062111","volume":"18","author":"MN Iriondo","year":"2022","unstructured":"Iriondo MN, Etxaniz A, Varela YR, Ballesteros U, Herv\u00e1s JH, Montes LR, Go\u00f1i FM, Alonso A. LC3 subfamily in cardiolipin-mediated mitophagy: a comparison of the LC3A, LC3B and LC3C homologs. Autophagy. 2022;18:2985\u20133003.","journal-title":"Autophagy"},{"key":"1399_CR48","doi-asserted-by":"publisher","first-page":"eadg8156","DOI":"10.1126\/sciadv.adg8156","volume":"9","author":"G Quarato","year":"2023","unstructured":"Quarato G, Mari L, Barrows NJ, Yang M, Ruehl S, Chen MJ, Guy CS, Low J, Chen T, Green DR. Mitophagy restricts BAX\/BAK-independent, parkin-mediated apoptosis. Sci Adv. 2023;9:eadg8156.","journal-title":"Sci Adv"},{"key":"1399_CR49","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41419-021-04184-8","volume":"12","author":"YC Han","year":"2021","unstructured":"Han YC, Tang SQ, Liu YT, Li AM, Zhan M, Yang M, Song N, Zhang W, Wu XQ, Peng CH, et al. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 2021;12:925.","journal-title":"Cell Death Dis"},{"key":"1399_CR50","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrm2434","volume":"9","author":"YP Ow","year":"2008","unstructured":"Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol. 2008;9:532\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1399_CR51","doi-asserted-by":"publisher","first-page":"797025","DOI":"10.3389\/fendo.2021.797025","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Liang W, Luo Q, Hu H, Yang K, Hu J, Chen Z, Zhu J, Feng J, Zhu Z, et al. PFKP activation ameliorates foot process Fusion in Podocytes in Diabetic Kidney Disease. Front Endocrinol (Lausanne). 2021;12:797025.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1399_CR52","doi-asserted-by":"publisher","first-page":"e13296","DOI":"10.1111\/cpr.13296","volume":"55","author":"Z Chen","year":"2022","unstructured":"Chen Z, Liang W, Hu J, Zhu Z, Feng J, Ma Y, Yang Q, Ding G. Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1-Drp1 signalling pathway. Cell Prolif. 2022;55:e13296.","journal-title":"Cell Prolif"},{"key":"1399_CR53","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4161\/auto.27191","volume":"10","author":"CT Chu","year":"2014","unstructured":"Chu CT, Bay\u0131r H, Kagan VE. LC3 binds externalized cardiolipin on injured mitochondria to signal mitophagy in neurons: implications for Parkinson Disease. Autophagy. 2014;10:376\u20138.","journal-title":"Autophagy"},{"key":"1399_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","volume":"27","author":"G Twig","year":"2008","unstructured":"Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo j. 2008;27:433\u201346.","journal-title":"Embo j"},{"key":"1399_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1399_CR56","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2021.10.028","volume":"101","author":"H Ma","year":"2022","unstructured":"Ma H, Guo X, Cui S, Wu Y, Zhang Y, Shen X, Xie C, Li J. Dephosphorylation of AMP-activated protein kinase exacerbates ischemia\/reperfusion-induced acute kidney injury via mitochondrial dysfunction. Kidney Int. 2022;101:315\u201330.","journal-title":"Kidney Int"},{"key":"1399_CR57","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s41401-023-01064-z","volume":"44","author":"MY Sun","year":"2023","unstructured":"Sun MY, Ye HJ, Zheng C, Jin ZJ, Yuan Y, Weng HB. Astragalin ameliorates renal injury in diabetic mice by modulating mitochondrial quality control via AMPK-dependent PGC1\u03b1 pathway. Acta Pharmacol Sin. 2023;44:1676\u201386.","journal-title":"Acta Pharmacol Sin"},{"key":"1399_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13293-021-00394-z","volume":"12","author":"L Grimbert","year":"2021","unstructured":"Grimbert L, Sanz MN, Gressette M, Rucker-Martin C, Novotova M, Solgadi A, Karoui A, Gomez S, Bedouet K, Jacquet E, et al. Spatiotemporal AMPK\u03b12 deletion in mice induces cardiac dysfunction, fibrosis and cardiolipin remodeling associated with mitochondrial dysfunction in males only. Biol Sex Differ. 2021;12:52.","journal-title":"Biol Sex Differ"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01399-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T09:46:10Z","timestamp":1706089570000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01399-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1399"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01399-4","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"9 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Care and Use Committee of Renmin Hospital of Wuhan University (Wuhan, China reference number WDRM.20220105\u00a0A) and were performed in compliance with the Guidelines for Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85\u201323, revised 1996). All research involving human subjects, including studies involving the collection of human renal biopsy samples and personal information, was approved by the Wuhan University Research Ethics Committee and conducted in accordance with the guidelines of Wuhan University. The investigation also adhered to the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}